SANTIS PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of SANTIS PHARMA is 1.7% (moderate). The 2025 annual accounts show equity of €640,449 and a net result of €1.2m. Equity remains stable across the filed financial years (±0.3% per year). The company has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- 1 more provision in the deed, see the deed of 09-09-2025
Read from the deeds: 1 provision, deed of 09-09-2025